Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole vs Risperidone in First-Episode Psychosis
NCT03883204Phase 4Unknown
- Sponsor
- Fundación Marqués de Valdecilla
- Start
- Jan 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia and psychotic disorder comparing Aripiprazole with Risperidone (2 arms). Primary endpoint: Global cognitive index at 3 years. Status: unknown.
02
Drugs
aripiprazolerisperidone
03
Conditions
schizophreniapsychotic disorder
Beyond the preview
Go deeper on NCT03883204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883204.